Literature DB >> 22526272

Autoimmune hepatitis: a review.

Andrea A Gossard1, Keith D Lindor.   

Abstract

Autoimmune hepatitis (AIH) is an inflammatory liver disease that predominantly affects females. The disease is characterized histologically by interface hepatitis, biochemically by increased aspartate and alanine aminotransferase levels, and serologically by the presence of autoantibodies and elevated levels of immunoglobulin G. AIH affects both adults and children, and is particularly aggressive in the latter group. It is a relatively rare but devastating disease, which progresses rapidly unless immunosuppressive treatment is started promptly. Treatment is often successful at inducing remission of disease, and this can lead to a normal life expectancy. However, progression to cirrhosis can and does occur in some. For those with advanced-stage disease and complications, consideration of liver transplantation is appropriate.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22526272     DOI: 10.1007/s00535-012-0586-z

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  56 in total

1.  Infliximab-induced autoimmune hepatitis in Crohn's disease treated with budesonide and mycophenolate.

Authors:  K Subramaniam; S Chitturi; M Brown; P Pavli
Journal:  Inflamm Bowel Dis       Date:  2011-08-30       Impact factor: 5.325

2.  Drug-induced autoimmune hepatitis caused by anti-tumor necrosis factor α agents.

Authors:  Cumali Efe; Tugrul Purnak; Ersan Ozaslan; Staffan Wahlin
Journal:  Hepatology       Date:  2010-07-16       Impact factor: 17.425

3.  Concurrent autoimmune thyroid diseases in patients with autoimmune hepatitis.

Authors:  Cumali Efe; Tugrul Purnak; Ersan Ozaslan
Journal:  J Clin Gastroenterol       Date:  2010-10       Impact factor: 3.062

4.  Diagnosis and management of autoimmune hepatitis.

Authors:  Michael P Manns; Albert J Czaja; James D Gorham; Edward L Krawitt; Giorgina Mieli-Vergani; Diego Vergani; John M Vierling
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

5.  Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapy.

Authors:  Kaveh Sharzehi; Mary Ann Huang; Ian R Schreibman; Kimberly A Brown
Journal:  Can J Gastroenterol       Date:  2010-10       Impact factor: 3.522

6.  Role of mycophenolate mofetil in the treatment of autoimmune hepatitis.

Authors:  Christoph Schramm; Ansgar W Lohse
Journal:  J Hepatol       Date:  2011-01-31       Impact factor: 25.083

7.  Prevalence of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.

Authors:  Alan Bonder; Alexandra Retana; Diana M Winston; John Leung; Marshall M Kaplan
Journal:  Clin Gastroenterol Hepatol       Date:  2011-04-11       Impact factor: 11.382

Review 8.  Coeliac disease in autoimmune liver disease: a cross-sectional study and a systematic review.

Authors:  Foroozandeh Mirzaagha; Sepideh Hagh Azali; Farhad Islami; Farhad Zamani; Elias Khalilipour; Morteza Khatibian; Reza Malekzadeh
Journal:  Dig Liver Dis       Date:  2010-03-17       Impact factor: 4.088

9.  Hepatocellular carcinoma in autoimmune hepatitis.

Authors:  S Z Park; D M Nagorney; A J Czaja
Journal:  Dig Dis Sci       Date:  2000-10       Impact factor: 3.199

10.  Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival.

Authors:  T Al-Chalabi; B C Portmann; W Bernal; I G McFarlane; M A Heneghan
Journal:  Aliment Pharmacol Ther       Date:  2008-04-23       Impact factor: 8.171

View more
  13 in total

1.  Absence of keratin 8 or 18 promotes antimitochondrial autoantibody formation in aging male mice.

Authors:  Diana M Toivola; Aida Habtezion; Julia O Misiorek; Linxing Zhang; Joel H Nyström; Orr Sharpe; William H Robinson; Raymond Kwan; M Bishr Omary
Journal:  FASEB J       Date:  2015-09-23       Impact factor: 5.191

2.  Abnormal intestinal permeability and microbiota in patients with autoimmune hepatitis.

Authors:  Rui Lin; Lu Zhou; Jie Zhang; Bangmao Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

3.  Cutting edge: chronic inflammatory liver disease in mice expressing a CD28-specific ligand.

Authors:  Emily Corse; Rachel A Gottschalk; Joon Seok Park; Manuel A Sepulveda; P'ng Loke; Timothy J Sullivan; Linda K Johnson; James P Allison
Journal:  J Immunol       Date:  2012-12-17       Impact factor: 5.422

Review 4.  Nuclear receptors as drug targets in cholestatic liver diseases.

Authors:  Emina Halilbasic; Anna Baghdasaryan; Michael Trauner
Journal:  Clin Liver Dis       Date:  2013-05       Impact factor: 6.126

5.  Occult hepatitis C virus infection in patients with autoimmune hepatitis.

Authors:  Mohammad Saeid Rezaee Zavareh; Seyed Moayed Alavian; Hamidreza Karimisari; Mostafa Shafiei; Seyed Yasser Saiedi Hosseini
Journal:  Hepat Mon       Date:  2014-08-10       Impact factor: 0.660

6.  Fucosterol Protects against Concanavalin A-Induced Acute Liver Injury: Focus on P38 MAPK/NF-κB Pathway Activity.

Authors:  Wenhui Mo; Chengfen Wang; Jingjing Li; Kan Chen; Yujing Xia; Sainan Li; Ling Xu; Xiya Lu; Wenwen Wang; Chuanyong Guo
Journal:  Gastroenterol Res Pract       Date:  2018-07-17       Impact factor: 2.260

Review 7.  Fucosterol of Marine Macroalgae: Bioactivity, Safety and Toxicity on Organism.

Authors:  Maria Dyah Nur Meinita; Dicky Harwanto; Gabriel Tirtawijaya; Bertoka Fajar Surya Perwira Negara; Jae-Hak Sohn; Jin-Soo Kim; Jae-Suk Choi
Journal:  Mar Drugs       Date:  2021-09-27       Impact factor: 5.118

8.  Presence of antibodies against self human leukocyte antigen class II molecules in autoimmune hepatitis.

Authors:  Satoshi Yamagiwa; Hiroteru Kamimura; Masaaki Takamura; Takuya Genda; Takafumi Ichida; Minoru Nomoto; Yutaka Aoyagi
Journal:  Int J Med Sci       Date:  2014-06-08       Impact factor: 3.738

9.  Analytical "bake-off" of whole genome sequencing quality for the Genome Russia project using a small cohort for autoimmune hepatitis.

Authors:  Daria V Zhernakova; Sergei Kliver; Nikolay Cherkasov; Gaik Tamazian; Mikhail Rotkevich; Ksenia Krasheninnikova; Igor Evsyukov; Sviatoslav Sidorov; Pavel Dobrynin; Andrey A Yurchenko; Valentin Shimansky; Irina V Shcherbakova; Andrey S Glotov; David L Valle; Minzhong Tang; Emilia Shin; Kathleen B Schwarz; Stephen J O'Brien
Journal:  PLoS One       Date:  2018-07-11       Impact factor: 3.240

10.  Analysis of Differentially Expressed Proteins Involved in Autoimmune Cirrhosis and Normal Serum by iTRAQ Proteomics.

Authors:  Zheng Minghui; Hu Kunhua; Bao Yunwen; Lu Hongmei; Li Jing; Wu Shaowen; Sun Longqiaozi; Duan Chaohui
Journal:  Proteomics Clin Appl       Date:  2018-08-09       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.